Home

1 Unpopular Stock That Deserves Some Love and 2 We Brush Off

TER Cover Image

When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other business lines such as M&A advisory.

At StockStory, we look beyond the headlines with our independent analysis to determine whether these bearish calls are justified. Keeping that in mind, here is one stock where Wall Street’s pessimism is creating a buying opportunity and two where the outlook is warranted.

Two Stocks to Sell:

Teradyne (TER)

Consensus Price Target: $116.06 (3.8% implied return)

Sporting most major chip manufacturers as its customers, Teradyne (NASDAQ:TER) is a US-based supplier of automated test equipment for semiconductors as well as other technologies and devices.

Why Do We Think Twice About TER?

  1. Flat sales over the last five years suggest it must find different ways to grow during this cycle
  2. Day-to-day expenses have swelled relative to revenue over the last five years as its operating margin fell by 14.4 percentage points
  3. Performance over the past five years shows each sale was less profitable, as its earnings per share fell by 4.4% annually

Teradyne’s stock price of $111.84 implies a valuation ratio of 28.2x forward P/E. To fully understand why you should be careful with TER, check out our full research report (it’s free).

STAAR Surgical (STAA)

Consensus Price Target: $24.14 (-14.5% implied return)

With over 2.5 million implants performed worldwide, STAAR Surgical (NASDAQ:STAA) designs and manufactures implantable lenses that correct vision problems without removing the eye's natural lens.

Why Is STAA Risky?

  1. Weak constant currency growth over the past two years indicates challenges in maintaining its market share
  2. Free cash flow margin dropped by 35.2 percentage points over the last five years, implying the company became more capital intensive as competition picked up
  3. Shrinking returns on capital suggest that increasing competition is eating into the company’s profitability

STAAR Surgical is trading at $28.25 per share, or 121.2x forward P/E. Check out our free in-depth research report to learn more about why STAA doesn’t pass our bar.

One Stock to Buy:

Cintas (CTAS)

Consensus Price Target: $220.06 (-0.7% implied return)

Starting as a family business collecting and cleaning shop rags in Cincinnati, Cintas (NASDAQ:CTAS) provides corporate identity uniforms, facility services, and safety products to over one million businesses across North America.

Why Is CTAS a Top Pick?

  1. Solid 8.3% annual revenue growth over the last two years indicates its offering’s solve complex business issues
  2. Share repurchases have amplified shareholder returns as its annual earnings per share growth of 16.7% exceeded its revenue gains over the last five years
  3. CTAS is a free cash flow machine with the flexibility to invest in growth initiatives or return capital to shareholders

At $221.71 per share, Cintas trades at 45.5x forward P/E. Is now the right time to buy? See for yourself in our full research report, it’s free.

High-Quality Stocks for All Market Conditions

When Trump unveiled his aggressive tariff plan in April 2025, markets tanked as investors feared a full-blown trade war. But those who panicked and sold missed the subsequent rebound that’s already erased most losses.

Don’t let fear keep you from great opportunities and take a look at Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today for free. Find your next big winner with StockStory today. Find your next big winner with StockStory today

StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.